| | |
Page
|
| |||
| | | | ii | | | |
| | | | iii | | | |
| | | | iii | | | |
| | | | iii | | | |
| | | | 1 | | | |
| | | | 16 | | | |
| | | | 18 | | | |
| | | | 20 | | | |
| | | | 65 | | | |
| | | | 68 | | | |
| | | | 69 | | | |
| | | | 78 | | | |
| | | | 79 | | | |
| | | | 80 | | | |
| | | | 93 | | | |
| | | | 116 | | | |
| | | | 122 | | | |
| | | | 132 | | | |
| | | | 134 | | | |
| | | | 135 | | | |
| | | | 136 | | | |
| | | | 146 | | | |
| | | | 157 | | | |
| | | | 159 | | | |
| | | | 179 | | | |
| | | | 181 | | | |
| | | | 182 | | | |
| | | | 183 | | | |
| | | | 184 | | | |
| | | | 186 | | | |
| | | | F-1 | | |
| | |
For the year ended December 31,
|
| |
For the three months ended March 31,
|
| ||||||||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |
2022
|
| |
2021
|
| |||||||||||||||
| | |
(in € million)
|
| |
(in € millions)
|
| ||||||||||||||||||||||||
Revenue
|
| | | | 0.0 | | | | | | — | | | | | | — | | | | |
|
0.0
|
| | | |
|
—
|
| |
Cost of sales
|
| | | | (0.0) | | | | | | — | | | | | | — | | | | | | (0.0) | | | | | | — | | |
Gross profit
|
| | | | (0.0) | | | | | | — | | | | | | — | | | | | | 0.0 | | | | | | — | | |
Cost of research and development
|
| | | | (40.6) | | | | | | (30.5) | | | | | | (4.9) | | | | | | (22.7) | | | | | | (2.4) | | |
Selling and distribution
expenses |
| | | | (3.2) | | | | | | (9.1) | | | | | | (2.1) | | | | | | (0.5) | | | | | | (0.8) | | |
General and administrative expenses
|
| | | | (15.1) | | | | | | (14.4) | | | | | | (2.4) | | | | | | (3.1) | | | | | | (3.9) | | |
Other operating income/
expenses |
| | | | (0.2) | | | | | | (0.0) | | | | | | 0.2 | | | | | | 0.8 | | | | | | 0.2 | | |
Impairment losses on financial assets
|
| | | | (0.0) | | | | | | (0.0) | | | | | | — | | | | | | (0.0) | | | | | | (0.0) | | |
Operating loss
|
| | | | (59.2) | | | | | | (54.0) | | | | | | (9.3) | | | | | | (25.5) | | | | | | (6.9) | | |
Interest and similar income
|
| | | | — | | | | | | 0.0 | | | | | | — | | | | |
|
—
|
| | | |
|
—
|
| |
Interest and similar expense
|
| | | | (4.8) | | | | | | (2.0) | | | | | | (0.7) | | | | | | (0.4) | | | | | | (2.3) | | |
Loss before tax
|
| | | | (63.9) | | | | | | (56.0) | | | | | | (10.0) | | | | | | (25.9) | | | | | | (9.2) | | |
Taxes on income
|
| | | | — | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Deferred taxes on expense
|
| | | | 0.0 | | | | | | — | | | | | | — | | | | | | — | | | | | | — | | |
Loss for the period
|
| | | | (64.0) | | | | | | (56.0) | | | | | | (10.0) | | | | | | (25.9) | | | | | | (9.2) | | |
Other comprehensive income (loss) that will not be reclassified to profit or loss
|
| | | | 0.0 | | | | | | (0.0) | | | | | | — | | | | | | — | | | | | | (0.0) | | |
Total comprehensive loss for the period
|
| | | | (63.9) | | | | | | (56.1) | | | | | | (10.0) | | | | | | (25.9) | | | | | | (9.3) | | |
| | |
For the year ended December 31,
|
| |
For the three months ended
March 31, |
| ||||||||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |
2022
|
| |
2021
|
| |||||||||||||||
| | |
(in € million)
|
| |
(in € millions)
|
| ||||||||||||||||||||||||
Loss per share in € | | | | | | | | | | | | | | | | | | | | | | ||||||||||
Basic/diluted(1)
|
| |
(1.07)/(1.07)
|
| |
(0.97)/(0.97)
|
| |
(0.18)/(0.18)
|
| |
(0.35)/(0.35)
|
| |
(0.15)/(0.15)
|
| |||||||||||||||
Weighted average number of share
for calculation of earnings per share |
| | | | | | | | | | | | | | | | | | | | | ||||||||||
Basic/diluted(1)
|
| | | | 59,836,824 | | | | | | 57,684,220 | | | | | | 56,860,720 | | | | | | 73,577,641 | | | | | | 61,223,465 | | |
| | |
For the year ended
December 31, |
| |
For the three months
ended March 31, |
| ||||||||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |
2022
|
| |
2021
|
| |||||||||||||||
| | |
(in € million)
|
| | | |||||||||||||||||||||||||
Net cash used in operating activities
|
| | | | (47.1) | | | | | | (1.2) | | | | | | (8.8) | | | | | | (29.6) | | | | | | (7.4) | | |
Net cash used in investing activities
|
| | | | (1.7) | | | | | | (0) | | | | | | (1.1) | | | | | | (0.2) | | | | | | (0.1) | | |
Net cash from (used in) financing activities
|
| | | | 138.6 | | | | | | 44.1 | | | | | | 8.8 | | | | | | (0.1) | | | | | | (0.3) | | |
Net (decrease) increase in cash and cash equivalents
|
| | | | 89.8 | | | | | | 42.9 | | | | | | (1.1) | | | | | | (29.9) | | | | | | (7.8) | | |
Cash and cash equivalents at the beginning of the period
|
| | | | 43.3 | | | | | | 0.4 | | | | | | 1.5 | | | | | | 132.9 | | | | | | 43.3 | | |
Cash and cash equivalents at end of period
|
| | | | 132.9 | | | | | | 43.3 | | | | | | 0.4 | | | | | | 103.0 | | | | | | 35.5 | | |
| | |
As of December 31,
|
| |
As of March 31,
|
| ||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |
2022
|
| ||||||||||||
| | |
(in € million)
|
| |
(in € millions)
|
| ||||||||||||||||||
Total non-current assets
|
| | | | 4.9 | | | | | | 4.1 | | | | | | 4.8 | | | | | | 5.0 | | |
Total current assets
|
| | | | 142.4 | | | | | | 49.2 | | | | | | 0.9 | | | | | | 117.6 | | |
Total assets
|
| | | | 147.3 | | | | | | 53.3 | | | | | | 5.7 | | | | | | 122.5 | | |
Total equity
|
| | | | 83.4 | | | | | | (5.0) | | | | | | (18.6) | | | | | | 58.3 | | |
Total liabilities
|
| | | | 63.9 | | | | | | 58.4 | | | | | | 24.3 | | | | | | 64.2 | | |
Total equity and liabilities
|
| | | | 147.3 | | | | | | 53.3 | | | | | | 5.7 | | | | | | 122.5 | | |
Assumed Average
Purchase Price Per Ordinary Share |
| |
Number of Registered
Ordinary Shares to be Issued if Full Purchase(1) |
| |
Percentage of Outstanding
Ordinary Shares After Giving Effect to the Issuance to the Selling Shareholder(2) |
| |
Gross Proceeds from the
sale of the Ordinary Shares to the Selling Shareholder Under the Purchase Agreement |
| |||||||||
$2.00
|
| | | | 17,500,000 | | | | | | 17.7% | | | | | $ | 35,000,000 | | |
$3.00
|
| | | | 17,500,000 | | | | | | 17.7% | | | | | $ | 52,500,000 | | |
$4.00
|
| | | | 17,500,000 | | | | | | 17.7% | | | | | $ | 70,000,000 | | |
$5.00
|
| | | | 17,500,000 | | | | | | 17.7% | | | | | $ | 87,500,000 | | |
$6.00
|
| | | | 17,500,000 | | | | | | 17.7% | | | | | $ | 105,000,000 | | |
| | |
As of December 31, 2021
|
| |||||||||
| | |
Actual
|
| |
Pro Forma
|
| ||||||
| | |
(in € millions)
|
| |||||||||
Cash and cash equivalents(1)
|
| | | | 132.9 | | | | | | 184.0 | | |
Long-term debt (including current portion)
|
| | | | 6.8 | | | | | | 6.8 | | |
Equity: | | | | | | | | | | | | | |
Subscribed capital(1)
|
| | | | 8.7 | | | | | | 9.8 | | |
Capital and other reserves
|
| | | | 221.8 | | | | | | 271.9 | | |
Accumulated deficit
|
| | | | (147.1) | | | | | | (147.1) | | |
Total equity
|
| | | | 83.4 | | | | | | 134.5 | | |
Total capitalization
|
| | | | 90.2 | | | | | | 141.3 | | |
| | |
For the year ended December 31,
|
| |
For the three months
ended March 31, |
| ||||||||||||||||||||||||
| | |
2021
|
| |
2020
|
| |
2019
|
| |
2022
|
| |
2021
|
| |||||||||||||||
| | |
(in € millions)
|
| |
(in € millions)
|
| ||||||||||||||||||||||||
Revenue
|
| | | | 0.0 | | | | | | — | | | | | | — | | | | | | 0.0 | | | | | | — | | |
Cost of sales
|
| | | | (0.0) | | | | | | — | | | | | | — | | | | | | (0.0) | | | | | | — | | |
Gross loss
|
| | | | (0.0) | | | | | | — | | | | | | — | | | | | | 0.0 | | | | | | — | | |
Cost of research and development
|
| | | | (40.6) | | | | | | (30.5) | | | | | | (4.9) | | | | | | (22.7) | | | | | | (2.4) | | |
Selling and distribution expenses
|
| | | | (3.2) | | | | | | (9.1) | | | | | | (2.1) | | | | | | (0.5) | | | | | | (0.8) | | |
General and administrative expenses
|
| | | | (15.1) | | | | | | (14.4) | | | | | | (2.4) | | | | | | (3.1) | | | | | | (3.9) | | |
Other operating income/expenses
|
| | | | (0.2) | | | | | | (0.0) | | | | | | 0.2 | | | | | | 0.8 | | | | | | 0.2 | | |
Impairment losses on financial assets
|
| | | | (0.0) | | | | | | (0.0) | | | | | | — | | | | | | (0.0) | | | | | | (0.0) | | |
Operating loss
|
| | | | (59.2) | | | | | | (54.0) | | | | | | (9.3) | | | | | | (25.5) | | | | | | (6.9) | | |
Interest and similar income
|
| | | | — | | | | | | 0.0 | | | | | | — | | | | | | — | | | | | | — | | |
Interest and similar expense
|
| | | | (4.8) | | | | | | (2.0) | | | | | | (0.7) | | | | | | (0.4) | | | | | | (2.3) | | |
Loss before tax
|
| | | | (63.9) | | | | | | (56.0) | | | | | | (10.0) | | | | | | (25.9) | | | | | | (9.2) | | |
Taxes on income
|
| | | | — | | | | | | — | | | | | | — | | | | | | 0.0 | | | | | | 0.0 | | |
Deferred taxes on expense
|
| | | | (0.0) | | | | | | — | | | | |